| 摘要 |
FIELD: biotechnology.SUBSTANCE: invention relates to biotechnology, namely to method of producing activated cytotoxic lymphocytes, and can be used in medicine. Peripheral mononuclears are recovered from blood of oncological patients or donors and then they are cultured in serum-free medium ex vivo with addition of recombinant human IL-2 in concentration from 125 ng/ml to 500 ng/ml and IL-15 in concentration from 2.5 ng/ml to 5 ng/ml.EFFECT: obtained cytotoxic lymphocytes with high output have high viability, proliferative activity and functional anticancer activity.3 cl, 8 dwg, 6 ex |
